Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Felber, J. P.
Right arrow Articles by DeFronzo, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Felber, J. P.
Right arrow Articles by DeFronzo, R. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 36, Issue 11 1341-1350, Copyright © 1987 by American Diabetes Association


ARTICLES

Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes

JP Felber, E Ferrannini, A Golay, HU Meyer, D Theibaud, B Curchod, E Maeder, E Jequier and RA DeFronzo
Institute of Clinical Physiology, University of Pisa, Italy.

Increased lipid oxidation is generally observed in subjects with obesity and diabetes and has been suggested to be responsible for the insulin resistance associated with these conditions. We measured, by continuous indirect calorimetry, lipid and glucose oxidation and nonoxidative glucose disposal in 82 obese subjects during a 100-g oral glucose tolerance test (OGTT) and in 26 during a euglycemic insulin (40 mU.min-1.m-2) clamp. The obese subjects were subdivided into those with normal glucose tolerance (group A), those with impaired glucose tolerance (group B), and those with overt diabetes (group C). Forty-five healthy nonobese subjects were subdivided into a young and an older control group, which were age-matched to the nondiabetic obese (groups A and B) and diabetic obese (group C) subjects, respectively. In the postabsorptive state, as well as in response to insulin stimulation (both OGTT and insulin clamp), lipid oxidation was significantly increased in all three obese groups in comparison with either young or older controls. Basal glucose oxidation was significantly decreased in obese nondiabetic and obese glucose--intolerant subjects (groups A and B) compared with age-matched controls. During the OGTT and during the insulin clamp, insulin-stimulated glucose oxidation was decreased in all three obese groups. In contrast, nonoxidative glucose disposal was markedly inhibited in nondiabetic and diabetic obese patients during the euglycemic insulin clamp but not during the OGTT. After glucose ingestion, nonoxidative glucose uptake was normal in nondiabetic obese and glucose-intolerant obese subjects and decreased in diabetic obese subjects. Statistical analysis revealed that lipid and glucose oxidation were strongly and inversely related in the basal state, during euglycemic insulin clamp, and during OGTT. The negative correlation between lipid oxidation and nonoxidative glucose uptake, although significant, was much weaker. Fasting and post-OGTT hyperglycemia were the strongest (negative) correlates of nonoxidative glucose disposal in both single and multiple regression models. We conclude that 1) reduced glucose oxidation and reduced nonoxidative glucose disposal partake of the insulin resistance of nondiabetic obese and diabetic obese individuals; 2) hyperglycemia provides a compensatory mechanism for the defect in nonoxidative glucose disposal in nondiabetic obese subjects; however, this compensation is characteristically lost when overt diabetes ensues; and 3) increased lipid oxidation may contribute, in part, to the defects in glucose oxidation and nonoxidative glucose uptake in obesity.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Koska, E. Ortega, C. Bogardus, J. Krakoff, and J. C. Bunt
The effect of insulin on net lipid oxidation predicts worsening of insulin resistance and development of type 2 diabetes mellitus
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E264 - E269.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Suwa, T. Egashira, H. Nakano, H. Sasaki, and S. Kumagai
Metformin increases the PGC-1{alpha} protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo
J Appl Physiol, December 1, 2006; 101(6): 1685 - 1692.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Z. Guo, L. Zhou, and M. D. Jensen
Acute hyperinsulinemia inhibits intramyocellular triglyceride synthesis in high-fat-fed obese rats
J. Lipid Res., December 1, 2006; 47(12): 2640 - 2646.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Yokoyama, M. Emoto, K. Mori, T. Araki, M. Teramura, H. Koyama, T. Shoji, M. Inaba, and Y. Nishizawa
Plasma Adiponectin Level Is Associated with Insulin-Stimulated Nonoxidative Glucose Disposal
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 290 - 294.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. J. Woerle, E. Szoke, C. Meyer, J. M. Dostou, S. D. Wittlin, N. R. Gosmanov, S. L. Welle, and J. E. Gerich
Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E67 - E77.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Bajaj, S. Suraamornkul, A. Romanelli, G. W. Cline, L. J. Mandarino, G. I. Shulman, and R. A. DeFronzo
Effect of a Sustained Reduction in Plasma Free Fatty Acid Concentration on Intramuscular Long-Chain Fatty Acyl-CoAs and Insulin Action in Type 2 Diabetic Patients
Diabetes, November 1, 2005; 54(11): 3148 - 3153.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. M. Poynten, S. K. Gan, A. D. Kriketos, L. V. Campbell, and D. J. Chisholm
Circulating Fatty Acids, Non-High Density Lipoprotein Cholesterol, and Insulin-Infused Fat Oxidation Acutely Influence Whole Body Insulin Sensitivity in Nondiabetic Men
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1035 - 1040.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. W. Castellani, P. Gargalovic, M. Febbraio, S. Charugundla, M.-L. Jien, and A. J. Lusis
Mechanisms mediating insulin resistance in transgenic mice overexpressing mouse apolipoprotein A-II
J. Lipid Res., December 1, 2004; 45(12): 2377 - 2387.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. P. Thyfault, R. M. Kraus, R. C. Hickner, A. W. Howell, R. R. Wolfe, and G. L. Dohm
Impaired plasma fatty acid oxidation in extremely obese women
Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1076 - E1081.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Bajaj, S. Suraamornkul, S. Kashyap, K. Cusi, L. Mandarino, and R. A. DeFronzo
Sustained Reduction in Plasma Free Fatty Acid Concentration Improves Insulin Action without Altering Plasma Adipocytokine Levels in Subjects with Strong Family History of Type 2 Diabetes
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4649 - 4655.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Iozzo, A. K. Turpeinen, T. Takala, V. Oikonen, J. Bergman, T. Gronroos, E. Ferrannini, P. Nuutila, and J. Knuuti
Defective Liver Disposal of Free Fatty Acids in Patients with Impaired Glucose Tolerance
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3496 - 3502.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. N. Lee, L. Zhang, D. Zheng, W. S. Choi, and J. H. Youn
Insulin suppresses PDK-4 expression in skeletal muscle independently of plasma FFA
Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E69 - E74.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. W. Hulver, J. R. Berggren, R. N. Cortright, R. W. Dudek, R. P. Thompson, W. J. Pories, K. G. MacDonald, G. W. Cline, G. I. Shulman, G. L. Dohm, et al.
Skeletal muscle lipid metabolism with obesity
Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E741 - E747.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Bajaj, T. Pratipanawatr, R. Berria, W. Pratipanawatr, S. Kashyap, K. Cusi, L. Mandarino, and R. A. DeFronzo
Free Fatty Acids Reduce Splanchnic and Peripheral Glucose Uptake in Patients With Type 2 Diabetes
Diabetes, October 1, 2002; 51(10): 3043 - 3048.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Bajaj, R. Berria, T. Pratipanawatr, S. Kashyap, W. Pratipanawatr, R. Belfort, K. Cusi, L. Mandarino, and R. A. DeFronzo
Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E346 - E352.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. H. Clerk, S. Rattigan, and M. G. Clark
Lipid Infusion Impairs Physiologic Insulin-Mediated Capillary Recruitment and Muscle Glucose Uptake In Vivo
Diabetes, April 1, 2002; 51(4): 1138 - 1145.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Pratipanawatr, K. Cusi, P. Ngo, W. Pratipanawatr, L. J. Mandarino, and R. A. DeFronzo
Normalization of Plasma Glucose Concentration by Insulin Therapy Improves Insulin-Stimulated Glycogen Synthesis in Type 2 Diabetes
Diabetes, February 1, 2002; 51(2): 462 - 468.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. V. Greco, G. Mingrone, A. Giancaterini, M. Manco, M. Morroni, S. Cinti, M. Granzotto, R. Vettor, S. Camastra, and E. Ferrannini
Insulin Resistance in Morbid Obesity: Reversal With Intramyocellular Fat Depletion
Diabetes, January 1, 2002; 51(1): 144 - 151.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. R. Srinivasan, L. Myers, and G. S. Berenson
Predictability of Childhood Adiposity and Insulin for Developing Insulin Resistance Syndrome (Syndrome X) in Young Adulthood: The Bogalusa Heart Study
Diabetes, January 1, 2002; 51(1): 204 - 209.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. Emilsson, J. O'Dowd, A. L. Nolan, and M. A. Cawthorne
Hexosamines and Nutrient Excess Induce Leptin Production and Leptin Receptor Activation in Pancreatic Islets and Clonal {beta}-Cells
Endocrinology, October 1, 2001; 142(10): 4414 - 4419.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. K. Moczulski, W. Grzeszczak, and B. Gawlik
Role of Hemochromatosis C282Y and H63D Mutations in HFE Gene in Development of Type 2 Diabetes and Diabetic Nephropathy
Diabetes Care, July 1, 2001; 24(7): 1187 - 1191.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. E. Kelley and B. H. Goodpaster
Skeletal Muscle Triglyceride: An aspect of regional adiposity and insulin resistance
Diabetes Care, May 1, 2001; 24(5): 933 - 941.
[Abstract] [Full Text]


Home page
DiabetesHome page
V. Rigalleau, C. Binnert, K. Minehira, N. Stefanoni, P. Schneiter, E. Henchoz, O. Matzinger, C. Cayeux, E. Jéquier, and L. Tappy
In Normal Men, Free Fatty Acids Reduce Peripheral but Not Splanchnic Glucose Uptake
Diabetes, April 1, 2001; 50(4): 727 - 732.
[Abstract] [Full Text]


Home page
DiabetesHome page
L. W. Castellani, A. M. Goto, and A. J. Lusis
Studies With Apolipoprotein A-II Transgenic Mice Indicate a Role for HDLs in Adiposity and Insulin Resistance
Diabetes, March 1, 2001; 50(3): 643 - 651.
[Abstract] [Full Text]


Home page
J. Am. Coll. Nutr.Home page
G. Benedetti, G. Mingrone, S. Marcoccia, M. Benedetti, A. Giancaterini, A. V. Greco, M. Castagneto, and G. Gasbarrini
Body Composition and Energy Expenditure after Weight Loss Following Bariatric Surgery
J. Am. Coll. Nutr., April 1, 2000; 19(2): 270 - 274.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. H. Cincotta, S. Luo, Y. Zhang, Y. Liang, K. G. Bina, T. L. Jetton, and P. W. D. Scislowski
Chronic infusion of norepinephrine into the VMH of normal rats induces the obese glucose-intolerant state
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2000; 278(2): R435 - R444.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. E. Kelley, B. Goodpaster, R. R. Wing, and J.-A. Simoneau
Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss
Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E1130 - E1141.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J.-A. SIMONEAU, JACQUES. H. VEERKAMP, L. P. TURCOTTE, and D. E. KELLEY
Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss
FASEB J, November 1, 1999; 13(14): 2051 - 2060.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. Barzilai, L. She, L. Liu, J. Wang, M. Hu, P. Vuguin, and L. Rossetti
Decreased visceral adiposity accounts for leptin effect on hepatic but not peripheral insulin action
Am J Physiol Endocrinol Metab, August 1, 1999; 277(2): E291 - E298.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. Rigalleau, M. Beylot, C. Pachiaudi, C. Guillot, G. Deleris, and H. Gin
Mechanisms of glucose intolerance during triglyceride infusion
Am J Physiol Endocrinol Metab, October 1, 1998; 275(4): E641 - E648.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
E. Ferrannini
Insulin Resistance versus Insulin Deficiency in Non-Insulin-Dependent Diabetes Mellitus: Problems and Prospects
Endocr. Rev., August 1, 1998; 19(4): 477 - 490.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J.-Y. Park, C.-H. Kim, S. K. Hong, K. I. Suh, and K.-U. Lee
Effects of FFA on insulin-stimulated glucose fluxes and muscle glycogen synthase activity in rats
Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E338 - E344.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Bianchi, R. Bigazzi, A. Q. Galvan, E. Muscelli, G. Baldari, N. Pecori, D. Ciociaro, E. Ferrannini, and A. Natali
Insulin Resistance in Microalbuminuric Hypertension : Sites and Mechanisms
Hypertension, November 1, 1995; 26(5): 789 - 795.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1987 by the American Diabetes Association.